Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 602 48 943.1 |
96 | EP file number | EAKZ | 08 00 2418.5 |
97 | EP publication number | EPN | 1923064 |
54 | Designation/title | TI | Verwendung von Aminpolymeren zur Minderung des Serumglukosegehaltes |
51 | IPC main class | ICM (ICMV) | A61K 31/785 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/787 (2006.01), A61P 3/10 (2006.01) |
22 | DE application date | DAT | Apr 10, 2002 |
96 | EP application date | EAT | Apr 10, 2002 |
43 | Date of first publication | OT | May 21, 2008 |
| Date of publication of grant | PET | Jun 28, 2017 |
71/73 | Applicant/owner | INH | Genzyme Corporation, Cambridge, Mass., US |
72 | Inventor | IN | Burke, Steven K., Sudbury, MA 01776, US |
| Address for service | | RWS Group, Translation Division, CHALFONT ST PETER, Bucks SL9 9FG, GB |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 305564 P Jul 13, 2001
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 284445 P Apr 18, 2001
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000001923064 Searchable text:
EP000001923064 Original document:
EP000001923064B1 Searchable text:
EP000001923064B1 |
43 | Date of first publication | EVT | May 21, 2008 |
| Date of the first transfer into DPMAregister | EREGT | May 27, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Apr 12, 2022 (Show all update days)(Hide all update days)- Apr 12, 2022; Mar 20, 2021; Apr 6, 2020; Aug 21, 2019; Apr 10, 2019; Jun 21, 2018; May 24, 2018; Sep 15, 2017; Aug 10, 2017; Jul 1, 2017; Jun 30, 2017; May 9, 2015; Feb 1, 2013
- Historical data not available for this/these date(s)
- May 27, 2011
- Date of the first transfer into DPMAregister
|